In Reply Thank you to Drs Dhana and Lehloenya for their comments and interest in our article examining mortality prediction in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in the United States.1 We recognize the limitations of retrospective studies in performing rigorous research in rare diseases like SJS/TEN but believe that despite the stated limitations of this study, it does provide valuable new information for the dermatology community.
Noe MH, Hubbard RA, Micheletti RG. The ABCD-10 Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—Reply. JAMA Dermatol. Published online July 31, 2019155(9):1088–1089. doi:10.1001/jamadermatol.2019.0998
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: